LEP and metabolic syndrome: The leptin-to-adiponectin ratio might, therefore, reflect the endocrine function of adipose tissue and provide a potentially useful measure of insulin resistance in subjects with obesity, metabolic syndrome, diabetes mellitus or non-diabetic mellitus [27–29].